Surgical Approach and Laser Applications in BRONJ Osteoporotic and Cancer Patients

Bisphosphonates-related Osteonecrosis of the Jaw (BRONJ) has been reported with increasing frequency in literature over last years, but its therapy is still a dilemma. One hundred ninety patients affected by BRONJ were observed between January 2004 and November 2011 and 166 treated sites were subdi...

Full description

Saved in:
Bibliographic Details
Main Authors: Paolo Vescovi, Elisabetta Merigo, Marco Meleti, Maddalena Manfredi, Carlo Fornaini, Samir Nammour
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Journal of Osteoporosis
Online Access:http://dx.doi.org/10.1155/2012/585434
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550015118082048
author Paolo Vescovi
Elisabetta Merigo
Marco Meleti
Maddalena Manfredi
Carlo Fornaini
Samir Nammour
author_facet Paolo Vescovi
Elisabetta Merigo
Marco Meleti
Maddalena Manfredi
Carlo Fornaini
Samir Nammour
author_sort Paolo Vescovi
collection DOAJ
description Bisphosphonates-related Osteonecrosis of the Jaw (BRONJ) has been reported with increasing frequency in literature over last years, but its therapy is still a dilemma. One hundred ninety patients affected by BRONJ were observed between January 2004 and November 2011 and 166 treated sites were subdivided in five groups on the basis of the therapeutical approach (medical or surgical, traditional or laser-assisted approach, with or without Low Level Laser Therapy (LLLT)). Clinical success has been defined for each treatment performed as clinical improvement or complete mucosal healing. Combination of antibiotic therapy, conservative surgery performed with Er:YAG laser and LLLT applications showed best results for cancer and noncancer patients. Nonsurgical approach performed on 69 sites induced an improvement in 35 sites (50.7%) and the complete healing in 19 sites (27.5%), while surgical approach on 97 sites induced an improvement in 84 sites (86.6%) and the complete healing in 78 sites (80.41%). Improvement and healing were recorded in 31 (81.5%) and 27 (71.5%) out of the 38 BRONJ sites treated in noncancer patients and in 88 (68.75%) and in 69 (53.9%) out of the 128 in cancer patients.
format Article
id doaj-art-8a0b051a52334040ad088655076dbec1
institution Kabale University
issn 2090-8059
2042-0064
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Journal of Osteoporosis
spelling doaj-art-8a0b051a52334040ad088655076dbec12025-02-03T06:08:01ZengWileyJournal of Osteoporosis2090-80592042-00642012-01-01201210.1155/2012/585434585434Surgical Approach and Laser Applications in BRONJ Osteoporotic and Cancer PatientsPaolo Vescovi0Elisabetta Merigo1Marco Meleti2Maddalena Manfredi3Carlo Fornaini4Samir Nammour5Oral Medicine, Pathology and Laser-Assisted Surgery Unit and Section of Dentistry, Department of ENT/Dental/Ophthalmological and Cervico-Facial Sciences, University of Parma, Via Gramsci, 14-43100 Parma, ItalyOral Medicine, Pathology and Laser-Assisted Surgery Unit and Section of Dentistry, Department of ENT/Dental/Ophthalmological and Cervico-Facial Sciences, University of Parma, Via Gramsci, 14-43100 Parma, ItalyOral Medicine, Pathology and Laser-Assisted Surgery Unit and Section of Dentistry, Department of ENT/Dental/Ophthalmological and Cervico-Facial Sciences, University of Parma, Via Gramsci, 14-43100 Parma, ItalyOral Medicine, Pathology and Laser-Assisted Surgery Unit and Section of Dentistry, Department of ENT/Dental/Ophthalmological and Cervico-Facial Sciences, University of Parma, Via Gramsci, 14-43100 Parma, ItalyOral Medicine, Pathology and Laser-Assisted Surgery Unit and Section of Dentistry, Department of ENT/Dental/Ophthalmological and Cervico-Facial Sciences, University of Parma, Via Gramsci, 14-43100 Parma, ItalyEuropean Master Degree in Oral Laser Applications (EMDOLA), University of Liège, Boulevard de la Constitution, 78-4020 Liège, BelgiumBisphosphonates-related Osteonecrosis of the Jaw (BRONJ) has been reported with increasing frequency in literature over last years, but its therapy is still a dilemma. One hundred ninety patients affected by BRONJ were observed between January 2004 and November 2011 and 166 treated sites were subdivided in five groups on the basis of the therapeutical approach (medical or surgical, traditional or laser-assisted approach, with or without Low Level Laser Therapy (LLLT)). Clinical success has been defined for each treatment performed as clinical improvement or complete mucosal healing. Combination of antibiotic therapy, conservative surgery performed with Er:YAG laser and LLLT applications showed best results for cancer and noncancer patients. Nonsurgical approach performed on 69 sites induced an improvement in 35 sites (50.7%) and the complete healing in 19 sites (27.5%), while surgical approach on 97 sites induced an improvement in 84 sites (86.6%) and the complete healing in 78 sites (80.41%). Improvement and healing were recorded in 31 (81.5%) and 27 (71.5%) out of the 38 BRONJ sites treated in noncancer patients and in 88 (68.75%) and in 69 (53.9%) out of the 128 in cancer patients.http://dx.doi.org/10.1155/2012/585434
spellingShingle Paolo Vescovi
Elisabetta Merigo
Marco Meleti
Maddalena Manfredi
Carlo Fornaini
Samir Nammour
Surgical Approach and Laser Applications in BRONJ Osteoporotic and Cancer Patients
Journal of Osteoporosis
title Surgical Approach and Laser Applications in BRONJ Osteoporotic and Cancer Patients
title_full Surgical Approach and Laser Applications in BRONJ Osteoporotic and Cancer Patients
title_fullStr Surgical Approach and Laser Applications in BRONJ Osteoporotic and Cancer Patients
title_full_unstemmed Surgical Approach and Laser Applications in BRONJ Osteoporotic and Cancer Patients
title_short Surgical Approach and Laser Applications in BRONJ Osteoporotic and Cancer Patients
title_sort surgical approach and laser applications in bronj osteoporotic and cancer patients
url http://dx.doi.org/10.1155/2012/585434
work_keys_str_mv AT paolovescovi surgicalapproachandlaserapplicationsinbronjosteoporoticandcancerpatients
AT elisabettamerigo surgicalapproachandlaserapplicationsinbronjosteoporoticandcancerpatients
AT marcomeleti surgicalapproachandlaserapplicationsinbronjosteoporoticandcancerpatients
AT maddalenamanfredi surgicalapproachandlaserapplicationsinbronjosteoporoticandcancerpatients
AT carlofornaini surgicalapproachandlaserapplicationsinbronjosteoporoticandcancerpatients
AT samirnammour surgicalapproachandlaserapplicationsinbronjosteoporoticandcancerpatients